SCM
ACHN

Sio Capital Management’s Achillion Pharmaceuticals ACHN Stock Holding History

Sio Capital Management’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-364,368
Closed -$2.52M – 51
2015
Q3 		$2.52M Buy
364,368
+117,368
+48% +$956K 1.73% 20
2015
Q2 		$2.19M Buy
+247,000
New +$2.34M 1.08% 29

Other funds holding ACHN

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Sio Capital Management's ACHN Position: Q4 2015 in Review

Sio Capital Management sold out of Achillion Pharmaceuticals (ACHN) in Q4 2015, closing a stake of 364,368 shares — an estimated $2.52M sold.

Sio Capital Management first reported a position in ACHN in Q2 2015 and held it in 2 quarters. The position peaked at $2.52M in Q3 2015. 152 funds tracked by Wall St. Rank hold ACHN as of Q4 2015.

  • Sio Capital Management reported no remaining Achillion Pharmaceuticals position as of Q4 2015 after selling out during the quarter.
  • Sio Capital Management sold 364,368 Achillion Pharmaceuticals shares in Q4 2015, an estimated $2.52M.
  • Sio Capital Management first reported a position in Achillion Pharmaceuticals in Q2 2015 and held it in 2 quarters.
  • Sio Capital Management's Achillion Pharmaceuticals position peaked at $2.52M in Q3 2015.
  • 152 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2015.

Based on Sio Capital Management's 13F filing for Q4 2015, filed 16 Feb 2016.